CD73: Unlocking Insights for Optimal Health and Wellness Solutions

Alpha Lifetech Incorporation is proud to present a revolutionary new product centered around the keyword CD7Our latest innovation harnesses the power of cd73, an ecto-enzyme known for its role in immuno-oncology. This groundbreaking product is designed to target and enhance the function of CD73, ultimately contributing to a more effective immune response against cancer, At Alpha Lifetech Incorporation, we are committed to advancing the field of immuno-oncology and bringing innovative solutions to the forefront of cancer treatment. With the introduction of our CD73-targeting product, we aim to contribute to the ongoing efforts to improve patient outcomes and revolutionize the way cancer is treated. Join us in this exciting journey towards a future where cancer is no longer a formidable foe

Hot Selling Product

ADT1678-Uliledlimab Biosimilar-(NT5E / CD73)-Research Biosimilar Antibody

ALP64654-Recombinant Human BTLA/CD272 Protein, Fc Tag

ADT1592-Sintilimab Biosimilar-Anti-PDCD1/PD1/CD279 mAb-Research Grade

ADT1049-Apolizumab Biosimilar-Anti-HLA-DRB mAb-Research Grade

ADT1440-Nimotuzumab Biosimilar-Anti-EGFR mAb-Research Grade

ADT1052-Ascrinvacumab Biosimilar-(ACVRL1/SKR3/TGF-B/TSR-I)-Research Biosimilar Antibody

Expert Choice of cd73 Delivers Unmatched Quality Factory

In a rapidly evolving biotech landscape, Alpha Lifetech Inc. stands out as a beacon of quality and innovation. Founded by a team of seasoned scientists with deep expertise in membrane Protein production, nanobody discovery, and monoclonal development, the company has committed itself to delivering unparalleled products to meet the diverse needs of global researchers and manufacturers. Our flagship offering, CD73, is a testament to this commitment, providing unmatched quality that is vital for advancing scientific discoveries and therapeutic developments. With nearly 10,000 high-quality reagents, cytokines, and drug target antibodies in our product lineup, Alpha Lifetech Inc. ensures that each item undergoes rigorous testing and quality assurance processes. The CD73 product, specifically, has been developed to support a variety of applications, including cancer research and immune modulation, making it an essential asset for laboratories striving for excellence. By choosing our CD73 products, procurement professionals can trust that they are aligning with a brand dedicated to scientific integrity and innovation. At Alpha Lifetech Inc., we understand the challenges faced by researchers in sourcing reliable and superior quality reagents. Our dedication to continuous improvement and customer satisfaction means that we not only provide exceptional products but also foster partnerships built on trust and collaboration. Together, we can push the boundaries of scientific research and help bring groundbreaking therapies to life. Join us in making a significant impact in the world of life sciences by choosing Alpha Lifetech Inc. for your procurement needs.

Expert Choice of CD73 Delivers Unmatched Quality Factory

Product ID	Product Name	Quality Rating	Stock Level	Price ($)
001	CD73 Enzyme Kit	5.0	150	200.00
002	Purified CD73 Protein	4.8	75	350.00
003	CD73 Assay Kit	4.9	120	180.00
004	CD73 Inhibitor	4.7	90	250.00
005	Anti-Cd73 Antibody	5.0	200	300.00

Annual Production Efficiency of CD73 Manufacturing

The chart above illustrates the annual production efficiency of CD73 manufacturing over a five-year period from 2019 to 2023. It signifies a consistent upward trend in efficiency, indicating improvements in manufacturing processes and technological advancements. In 2019, the production efficiency started at 75%, reflecting the initial capabilities of the manufacturing facility. Over the following years, each subsequent year showed marked improvement, with 2023 reaching an impressive efficiency of 95%. This consistent increase not only highlights the commitment to quality and optimization but also allows manufacturers to meet rising demands while maintaining high standards. Increased efficiency is crucial for businesses to remain competitive, reduce costs, and ensure product reliability. Overall, the data reflects a successful strategy in manufacturing CD73, hinting at the potential for further enhancements in the years to come.